News for Immunic, Inc. (10VA.F)

Published at

Mar 2, 2021 12:30 PM

by thestreet.com

neutral

neutral

Immunic, Inc. To Participate In Industry And Investor Conferences In March

NEW YORK, March 2, 2021 /PRNewswire/ -- Immunic, Inc.(Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral

IMUX 10VA.MU 10VA.F 10VA.BE

Read more →
Published at

Feb 26, 2021 3:45 PM

by investorideas.com

mixed

mixed

Biotech Stock News: Immunic, Inc. (NASDAQ: IMUX) Reports Year End 2020 Financial Results and Highlights Recent Activity

NEW YORK - February 26, 2021 (Investorideas.com Newswire) Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of sele...

SOK.SG SOK.MU SOK.F SKXJF D4S.DU 6417.T IMUX 10VA.MU 10VA.F 10VA.BE

Read more →
Published at

Feb 17, 2021 4:30 PM

by investorideas.com

neutral

neutral

Immunic, Inc. Announces That Oral Treatment IMU-838 Shows Evidence of Clinical Activity in Moderate COVID-19 in Phase 2 CALVID-1 Trial

NEW YORK - February 17, 2021 (Investorideas.com Newswire) Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of sele...

IMUX 10VA.MU 10VA.F 10VA.BE

Read more →
Published at

Feb 17, 2021 1:26 PM

by benzinga.com

mixed

mixed

The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 16) 10X ...

YMAB US87166B1026.SG TLIS SYNH SNCA SESN SEEL PTGX PRTA PPD PCBK.MU PCBK.F PCBK.BE PAVM ORMP NXEN.SG NXEN.F NXEN.BE NK NG9.MU NG9.F NG9.BE NEO.MX NEO NARI MDT KRYS ITCI IMUX HZNP HPR.MU HPR.F GTHX GNMK GMED GM0N.F GM0N.BE G1H.F G1H.BE EXK.SG EXK.MU EXK.F EXK.BE EXAS ET82.SG ET82.MU ET82.F ET82.DU ET82.BE EPIX E031.F DRIO DP81.SG DP81.F DP81.BE DMTK DFFN CTXR CBLI BP2M.F BP2M.BE BNTXN.MX BNTX AIKI AEZS.TO AEZS ADAP 8IN.MU 8IN.F 4KB.SG 4KB.F 4KB.BE 47N.F 473A.MU 473A.F 473A.BE 2M6.MU 2M6.F 2M6.DE 2M6.BE 23I.MU 23I.F 23I.BE 22UA.MU 22UA.F 22UA.DE 22UA.BE 1P5.SG 1P5.F 10VA.MU 10VA.F 10VA.BE 0PT.F ZEGA.SG ZEGA.MU ZEGA.F ZEGA.BE ZEG.SG ZEG.MU ZEG.F ZEG.DE ZEG.BE VKTX VCYT VAR TXG TECH TE1.MU TE1.F TE1.BE SXTC SWAV RPRX RPD.MU RPD.F ORMP.TA ONCT OJU1.MU OJU1.F OJU1.BE NVTA.MX NVTA NVSN.MX NVSEF NVS NOVN.SW NOTA.MU NOTA.F NOTA.BE NMTR MRK.PA MRK.MX MRK IV8.MU IV8.F IV8.BE IRWD INSP I76.F GXEA.F GXEA.BE GTU2.MU GTU2.F GLPG EVAX CTLT CLPT CERC C6K.F BPMC BNGO.MX BNGO BGNE BASI AZNN.MX AZNCF AZN.L AZN AVNS ASLN ANGN AMTI AGTC 8HH.MU 8HH.F 8HH.BE 7CB1.F 7CB1.BE 7A9.MU 7A9.F 7A9.BE 6MK.MU 6MK.F 6MK.DE 6MK.BE 6160.HK 49BA.SG 36M.MU 36M.F 36M.BE 2Y3.MU 2Y3.BE 2Q3.F 2Q3.BE 2L9.F 2L9.BE 2GT.MU 2GT.F 2GT.BE 2DR.MU 2DR.F 2DR.BE 1VT.MU 1VT.F 1VT.BE 1KJ.MU 1KJ.F 1KJ.BE 12V.F 12V.BE 0C8.MU 0C8.F 0C8.BE PFED.BA PFE.SG PFE.MX PFE.MU PFE.F PFE.DE PFE.BE PFE GENE DBTX BVS BLUE BLE.MU BLE.F AMGN.BA AMGN AMG.MU AMG.F AMG.DE AMG.BE

Read more →
Published at

Feb 17, 2021 1:26 PM

by markets.businessinsider.com

mixed

mixed

Immunic's IMU-838 Shows Evidence Of Clinical Activity In Moderate COVID-19 In Phase2 Trial

(RTTNews) - Immunic Inc. (IMUX) said that its selective oral DHODH inhibitor, IMU-838, has shown evidence of clinical activity in hospitalized pat...

IMUX 10VA.MU 10VA.F 10VA.BE KEY

Read more →
Published at

Feb 17, 2021 12:30 PM

by prnewswire.com

neutral

neutral

Immunic, Inc. Announces That Oral Treatment IMU-838 Shows Evidence of Clinical Activity in Moderate COVID-19 in Phase 2 CALVID-1 Trial

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at...

IMUX 10VA.MU 10VA.F 10VA.BE

Read more →